GRIA2 and breast carcinoma: Among those are the ionotropic glutamate receptor AMPA type subunit 2 (GRIA2) and the γ-aminobutyric acid receptor type A (GABAAR) in brain metastases of melanoma [70] and breast cancer [71], respectively.